Esther Y. Yoon, M.D., M.P.H.
Assistant Professor, Department of Pediatrics and Communicable Diseases
300 North Ingalls 6E07
Dr. Yoon's research focuses on best-informed pediatric prescribing practice through evaluation of factors influencing physician decision-making in management of common pediatric conditions such as hypertension and asthma. Her current research focuses on pharmacologic management of hypertension in children and adolescents with particular interest in issues involving co-management of pediatric hypertension between providers of different specialties.
Other research interests include medication safety, FDA-approval of medications for pediatric use (pediatric labeling) and effective dissemination of new or revised medication information to providers at point of care.
M.P.H., Epidemiology, University of Michigan School of Public Health, 2005
M.D., Wayne State University School of Medicine, 2000
B.S., Anthropology-Zoology, University of Michigan, 1995
B.S., Biology, University of Michigan, 1995
Use of Antihypertensive Medications and Diagnostic Tests Among Privately-insured Adolescents and Young Adults with Essential vs. Secondary Hypertension.
Journal of Adolescent Health. In press.
Underlying rationale and approach to treat hypertension in adolescents by physician of different specialty.
Ann Pediatr Child Health. 2013;1(1):1005.
Use of diagnostic tests in adolescents with essential hypertension.
Archives of Pediatrics and Adolescent Medicine. 2012; 166(9):85-862.
Clonidine utilization trends for Medicaid children.
Clinical Pediatrics. 2012; 51(10):950-955.
Antihypertensive prescribing patterns for adolescents with primary hypertension.
Diagnosis of diabetes using hemoglobin A1c: should recommendations in adults be extrapolated to adolescents?
J Pediatr. 2011;158(6):947-952.e1-3. Epub 2010 Dec 30.
Parental preferences for FDA-approved medications prescribed for their children.
Clinical Pediatrics 2011;50(3):208-14. [Epub 2010 Nov 22].
Differences in pediatric drug information sources used by general versus subspecialist pediatricians.
Clinical Pediatrics 2010;49(8):743-9. [Epub 2010 Jun 3].
Formulary coverage for antihypertensive drugs used in children
Am J Pharm Benefits 2009;1(3):145-149.
Formulary coverage for lipid-lowering drugs recommended for children.
Clinical Pediatrics 2009 Jul; 48(6):609-13.
Medical management of children with primary hypertension by pediatric subspecialists.
Pediatr Nephrol 2009 24:147-153.
The need for and creation of a comprehensive pediatric research network.
Paediatr Drugs 2008;10(5):279-280.
Off-label utilization of antihypertensive medications in children.
Ambul Pediatr 2007;7:299-303.
FDA labeling status of pediatric medications.
Clin Pediatr (Phila) 2006;45:75-78.
Variation in pediatric asthma quality improvement programs by managed care plans.
Am J of Med Qual 2005; 20:204-209.
Factors associated with non-attendance at pediatric subspecialty asthma clinics.
J Asthma 2005;42:555-559.